Pharmacological inhibition of sphingosine kinase 1 (SPHK1) using agents like MP-A08 restores Cer levels, triggering integrated stress responses and sensitizing FLT3-ITD AML cells to apoptosis—particularly when combined with venetoclax [108,109]. The gene discussed is FLT3; the disease is acute myeloid leukemia.